Isis Pharmaceuticals, Inc. (ISIS) Posts Q2 EPS Loss of $0.18
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) reported Q2 EPS of ($0.18), $0.04 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $24.8 million versus the consensus estimate of $23.98 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pepsi (PEP) Tops Q3 EPS by 8c
- Actuant (ATU) Reports Q4 EPS of $0.29; Offers FY17 Guidance
- National American University Holdings (NAUH) Reports Q1 Loss of $0.09/Share
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!